Illumina Sues Genoma SA

San Diego-based life sciences equipment maker Illumina said Thursday afternoon that it has filed a patent infringement suit against Genoma SA, over infringement on non-invasive prenatal testing (NIPT) patents. The lawsuit was filed in the Federal Patent Court in Switzerland. Illumina claims Genoma SA has been infringing upon European Patent (CH) 2 183 693 B1, European Patent (CH) 0 994 963 B2, European Patent (CH) 1 981 995 B1, and European Patent (CH) 2 514 842, all related to non-invasive prenatal testing.